REGN Regeneron Pharmaceuticals, Inc. | US75886F1075
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 68.775.452.672 | 81.140.449.223,78 | 81.599.892.966,82 | 59.216.673.738,4 |
| Enterprise Value | 60.694.323.200 | 80.884.049.223,78 | 81.187.692.966,82 | 59.415.773.738,4 |
| Trailing P/E | 16,02 | 18,34 | 18,11 | 16,18 |
| Forward P/E | 12,01 | - | - | - |
| Price to Sales | 4,61 | 5,44 | 5,69 | 5,66 |
| Price to Book | 2,13 | 2,58 | 2,61 | 1,91 |
| EV/Revenue | 4,07 | 5,42 | 5,66 | 5,68 |
| EV/EBITDA | 13,85 | 15,81 | 16,28 | 15,86 |